Standard InChI: InChI=1S/C24H20O6S/c25-17-10-6-15(7-11-17)22-20-14-21(31(27,28)30-19-4-2-1-3-5-19)24(29-20)23(22)16-8-12-18(26)13-9-16/h1-13,20-21,24-26H,14H2
1.He M,Ning W,Hu Z,Huang J,Dong C,Zhou HB. (2020) Design, synthesis and biological evaluation of novel dual-acting modulators targeting both estrogen receptor α (ERα) and lysine-specific demethylase 1 (LSD1) for treatment of breast cancer., 195 [PMID:32283297][10.1016/j.ejmech.2020.112281]
2.Zhao C, Tang C, Li C, Ning W, Hu Z, Xin L, Zhou HB, Huang J.. (2021) Novel hybrid conjugates with dual estrogen receptor α degradation and histone deacetylase inhibitory activities for breast cancer therapy., 40 [PMID:33965842][10.1016/j.bmc.2021.116185]
3.Deng X, Xie B, Li Q, Xiao Y, Hu Z, Deng X, Fang P, Dong C, Zhou HB, Huang J.. (2022) Discovery of Novel Bicyclic Phenylselenyl-Containing Hybrids: An Orally Bioavailable, Potential, and Multiacting Class of Estrogen Receptor Modulators against Endocrine-Resistant Breast Cancer., 65 (11.0):[PMID:35611405][10.1021/acs.jmedchem.2c00525]